BSBR heads into its October 29 earnings date with a modest price recovery underway but a Street that has largely walked away from the stock.
The most striking feature of the current setup is not positioning — it is the analyst picture. The analyst recommendation differential ranks in the 99th percentile, meaning consensus is more skewed toward buy ratings than nearly every other stock in the ORTEX universe. That would ordinarily be a bullish signal. But the dividend data dried up after April 2022, earnings-surprise history ranks just 14th percentile, and forward EPS momentum over both 30 and 90 days is at the bottom of the distribution — 2nd and 3rd percentile respectively. The Street's enthusiasm has not been earned by the numbers lately.
Short sellers have little footprint here. The short score rank is in the 98th percentile — meaning borrow demand is among the lowest in the universe — and utilization rank sits at the 89th percentile from the bottom, confirming the lending market is loose. There is no meaningful squeeze pressure, no evidence of aggressive directional bets against the name, and nothing in the borrow conditions that would generate a catalyst from that angle. This is not a short story; it is a valuation and macro story.
The price action is quietly improving. BSBR closed at ARS 9,345 on August 28, up 1.1% on the day, 2.3% on the week, and 6.6% over the past month. That monthly move is real but context matters — earlier notes had flagged the stock trading near 52-week lows, weighed down by Brazilian rate expectations and real depreciation. The slow grind higher suggests some stabilisation rather than a re-rating.
Institutional flow adds a faint contrarian note. State Street added 4 million shares as of July 31 — a material move relative to its prior position. Marshall Wace built a new stake of 1.95 million shares as of June 30, and Morgan Stanley added 1.75 million over the same period. Those are notable flows for a stock that the macro narrative has been pressing lower. Whether that reflects a view on Brazil's rate cycle turning or simply a rebalancing is unclear, but the direction of institutional money is worth noting alongside the price recovery.
The most important near-term data point is the July 29 earnings print. The stock fell 10.2% the day results landed, before recovering 3.8% over the following five days. That asymmetric reaction — a hard initial drop, then a partial bounce — is the pattern to hold in mind heading into the October 28 event. The question then will be whether any improvement in net interest margins or credit quality offsets the pressure that macro headwinds have applied to forward estimates.
See the live data behind this article on ORTEX.
Open BSBR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
